Selected research
Industry Research
Orlistat Industry Research Report 2026
Market perspective
The global Orlistat market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Orlistat is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Orlistat is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Orlistat include Teva, Sandoz(Novartis), Roche, GSK group, ZEIN pharmaceutical, Taj Pharmaceuticals Ltd, STADA-VN J.V.Co., Ltd, National Company for Pharmaceutical Industry and Lunan Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Orlistat market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Orlistat Market by Company
Teva
Sandoz(Novartis)
Roche
GSK group
ZEIN pharmaceutical
Taj Pharmaceuticals Ltd
STADA-VN J.V.Co., Ltd
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Kabir Life Sciences & Research
HISUN
Hexal AG
DM Pharma
China Zhongshan Pharm
Orlistat Segment by Type
120mg Orlistat
60mg Orlistat
Orlistat Segment by Application
Weight-reducing Aid
Other
Orlistat Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orlistat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orlistat and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orlistat.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orlistat manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orlistat by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orlistat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 120mg Orlistat
- 60mg Orlistat
Applications
- Weight-reducing Aid
- Other
Companies covered
- Teva
- Sandoz(Novartis)
- Roche
- GSK group
- ZEIN pharmaceutical
- Taj Pharmaceuticals Ltd
- STADA-VN J.V.Co., Ltd
- National Company for Pharmaceutical Industry
- Lunan Pharmaceutical Group Corporation
- Kabir Life Sciences & Research
- HISUN
- Hexal AG
- DM Pharma
- China Zhongshan Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Orlistat Market Size (2021-2032)
- 2.2.2 Global Orlistat Sales (2021-2032)
- 2.2.3 Global Orlistat Market Average Price (2021-2032)
- 2.3 Orlistat by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 120mg Orlistat
- 2.3.3 60mg Orlistat
- 2.4 Orlistat by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Weight-reducing Aid
- 2.4.3 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Orlistat Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Orlistat Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Orlistat Revenue of Manufacturers (2021-2026)
- 3.4 Global Orlistat Average Price by Manufacturers (2021-2026)
- 3.5 Global Orlistat Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Orlistat, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Orlistat, Product Type & Application
- 3.8 Global Manufacturers of Orlistat, Established Date
- 3.9 Global Orlistat Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Orlistat Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sandoz(Novartis)
- 4.2.1 Sandoz(Novartis) Company Information
- 4.2.2 Sandoz(Novartis) Business Overview
- 4.2.3 Sandoz(Novartis) Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz(Novartis) Orlistat Product Portfolio
- 4.2.5 Sandoz(Novartis) Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Orlistat Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 GSK group
- 4.4.1 GSK group Company Information
- 4.4.2 GSK group Business Overview
- 4.4.3 GSK group Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GSK group Orlistat Product Portfolio
- 4.4.5 GSK group Recent Developments
- 4.5 ZEIN pharmaceutical
- 4.5.1 ZEIN pharmaceutical Company Information
- 4.5.2 ZEIN pharmaceutical Business Overview
- 4.5.3 ZEIN pharmaceutical Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ZEIN pharmaceutical Orlistat Product Portfolio
- 4.5.5 ZEIN pharmaceutical Recent Developments
- 4.6 Taj Pharmaceuticals Ltd
- 4.6.1 Taj Pharmaceuticals Ltd Company Information
- 4.6.2 Taj Pharmaceuticals Ltd Business Overview
- 4.6.3 Taj Pharmaceuticals Ltd Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taj Pharmaceuticals Ltd Orlistat Product Portfolio
- 4.6.5 Taj Pharmaceuticals Ltd Recent Developments
- 4.7 STADA-VN J.V.Co., Ltd
- 4.7.1 STADA-VN J.V.Co., Ltd Company Information
- 4.7.2 STADA-VN J.V.Co., Ltd Business Overview
- 4.7.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 STADA-VN J.V.Co., Ltd Orlistat Product Portfolio
- 4.7.5 STADA-VN J.V.Co., Ltd Recent Developments
- 4.8 National Company for Pharmaceutical Industry
- 4.8.1 National Company for Pharmaceutical Industry Company Information
- 4.8.2 National Company for Pharmaceutical Industry Business Overview
- 4.8.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 National Company for Pharmaceutical Industry Orlistat Product Portfolio
- 4.8.5 National Company for Pharmaceutical Industry Recent Developments
- 4.9 Lunan Pharmaceutical Group Corporation
- 4.9.1 Lunan Pharmaceutical Group Corporation Company Information
- 4.9.2 Lunan Pharmaceutical Group Corporation Business Overview
- 4.9.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio
- 4.9.5 Lunan Pharmaceutical Group Corporation Recent Developments
- 4.10 Kabir Life Sciences & Research
- 4.10.1 Kabir Life Sciences & Research Company Information
- 4.10.2 Kabir Life Sciences & Research Business Overview
- 4.10.3 Kabir Life Sciences & Research Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kabir Life Sciences & Research Orlistat Product Portfolio
- 4.10.5 Kabir Life Sciences & Research Recent Developments
- 4.11 HISUN
- 4.11.1 HISUN Company Information
- 4.11.2 HISUN Business Overview
- 4.11.3 HISUN Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HISUN Orlistat Product Portfolio
- 4.11.5 HISUN Recent Developments
- 4.12 Hexal AG
- 4.12.1 Hexal AG Company Information
- 4.12.2 Hexal AG Business Overview
- 4.12.3 Hexal AG Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hexal AG Orlistat Product Portfolio
- 4.12.5 Hexal AG Recent Developments
- 4.13 DM Pharma
- 4.13.1 DM Pharma Company Information
- 4.13.2 DM Pharma Business Overview
- 4.13.3 DM Pharma Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 DM Pharma Orlistat Product Portfolio
- 4.13.5 DM Pharma Recent Developments
- 4.14 China Zhongshan Pharm
- 4.14.1 China Zhongshan Pharm Company Information
- 4.14.2 China Zhongshan Pharm Business Overview
- 4.14.3 China Zhongshan Pharm Orlistat Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 China Zhongshan Pharm Orlistat Product Portfolio
- 4.14.5 China Zhongshan Pharm Recent Developments
5 Global Orlistat Market Scenario by Region
- 5.1 Global Orlistat Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Orlistat Sales by Region: 2021-2032
- 5.2.1 Global Orlistat Sales by Region: 2021-2026
- 5.2.2 Global Orlistat Sales by Region: 2027-2032
- 5.3 Global Orlistat Revenue by Region: 2021-2032
- 5.3.1 Global Orlistat Revenue by Region: 2021-2026
- 5.3.2 Global Orlistat Revenue by Region: 2027-2032
- 5.4 North America Orlistat Market Facts & Figures by Country
- 5.4.1 North America Orlistat Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Orlistat Sales by Country (2021-2032)
- 5.4.3 North America Orlistat Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Orlistat Market Facts & Figures by Country
- 5.5.1 Europe Orlistat Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Orlistat Sales by Country (2021-2032)
- 5.5.3 Europe Orlistat Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Orlistat Market Facts & Figures by Country
- 5.6.1 Asia Pacific Orlistat Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Orlistat Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Orlistat Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Orlistat Market Facts & Figures by Country
- 5.7.1 South America Orlistat Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Orlistat Sales by Country (2021-2032)
- 5.7.3 South America Orlistat Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Orlistat Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Orlistat Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Orlistat Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Orlistat Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Orlistat Sales by Type (2021-2032)
- 6.1.1 Global Orlistat Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Orlistat Sales Market Share by Type (2021-2032)
- 6.2 Global Orlistat Revenue by Type (2021-2032)
- 6.2.1 Global Orlistat Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Orlistat Revenue Market Share by Type (2021-2032)
- 6.3 Global Orlistat Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Orlistat Sales by Application (2021-2032)
- 7.1.1 Global Orlistat Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Orlistat Sales Market Share by Application (2021-2032)
- 7.2 Global Orlistat Revenue by Application (2021-2032)
- 7.2.1 Global Orlistat Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Orlistat Revenue Market Share by Application (2021-2032)
- 7.3 Global Orlistat Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Orlistat Value Chain Analysis
- 8.1.1 Orlistat Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Orlistat Production Mode & Process
- 8.2 Orlistat Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Orlistat Distributors
- 8.2.3 Orlistat Customers
9 Global Orlistat Analyzing Market Dynamics
- 9.1 Orlistat Industry Trends
- 9.2 Orlistat Industry Drivers
- 9.3 Orlistat Industry Opportunities and Challenges
- 9.4 Orlistat Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst